Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

When Transforming Growth Factor ß family precursor proteins are ectopically expressed in Xenopus laevis embryos, they dimerize, get cleaved and are secreted into the blastocoele, which begins at the late blastula to early gastrula stage. We describe a method for aspirating cleavage products from the blastocoele cavity for immunoblot analysis.

Abstract

The two arms of the Transforming Growth Factor ß (Tgfß) superfamily, represented by Tgfß/Nodal or Bone morphogenetic protein (Bmp) ligands, respectively, play essential roles in embryonic development and adult homeostasis. Members of the Tgfß family are made as inactive precursors that dimerize and fold within the endoplasmic reticulum. The precursor is subsequently cleaved into ligand and prodomain fragments. Although only the dimeric ligand can engage Tgfß receptors and activate downstream signaling, there is growing recognition that the prodomain moiety contributes to ligand activity. This article describes a protocol that can be used to identify cleavage products generated during activation of Tgfß precursor proteins. RNA encoding Tgfß precursors are first microinjected into X. laevis embryos. The following day, cleavage products are collected from the blastocoele of gastrula stage embryos and analyzed on Western blots. This protocol can be completed relatively quickly, does not require expensive reagents and provides a source of concentrated Tgfß cleavage products under physiologic conditions.

Introduction

Members of the Transforming Growth Factor ß (Tgfß) superfamily are synthesized as inactive, dimerized precursor proteins. The precursors are then cleaved by members of the proprotein convertase (PC) family, either within the secretory pathway or outside of cells. This creates an active, disulfide-bonded ligand dimer and two prodomain fragments1. Although it has been known for over 30 years that the prodomain of Tgfß family precursors is required to generate an active ligand2, the understanding of how prodomains contribute to ligand function is incomplete.

Although the understand....

Protocol

All procedures described are approved by the Institutional Animal Care and Use Committee (IACUC) of the University of Utah. Frogs are housed in an IACUC approved facility. Male frogs are euthanized by immersion in tricaine following by clipping the ventricle of the heart. Female frogs are housed in the laboratory for a maximum of 24 h following hormonal induction of spawning to allow for egg collection and then returned to the care facility.

1. Collection of X. laevis Testes

    .......

Representative Results

The experiment's goal described below was to determine whether Bmp4 and Bmp7 form heterodimers (dimers composed of one Bmp4 ligand and one Bmp7 ligand), homodimers (composed of two Bmp4 or two Bmp7 ligands), or a mixture of each when they are co-expressed in X. laevis. Data shown in Figure 2 are extracted from a previously published study10. Figure 2A is a schematic showing cleavage products generated by proteolytic maturatio.......

Discussion

The main advantages to the protocol described here are that it can be completed relatively quickly, does not require expensive reagents and provides a source of concentrated Tgfß cleavage products under physiologic conditions. Another advantage is that it allows one to analyze epitope-tagged proteins and thus circumvent the shortage of commercially available antibodies that recognize most Tgfß family prodomain. Although it is also possible to analyze the cleavage of epitope-tagged Tgfß precursor proteins i.......

Acknowledgements

We thank Mary Sanchez for excellent animal care. The authors' research is supported by the National Institute of Child Health and Human Development of the National Institutes of Health (NIH/NICHD) grants R01HD067473-08 and R21 HD102668-01 and by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK/NIH) grant R01DK128068-01.

....

Materials

NameCompanyCatalog NumberComments
ß-mercaptoethanolFisherAC125470100
Bromophenol BlueFisherB392-5
Calcium ChlorideFisherC79-500
Calcium NitrateFisherC109-500
Disposable Pellet Pestle/Tissue GrinderFisher12-141-364
Dumont #5 forcepsFine Science tools11251-10
Fetal Bovine SerumAtlanta BiologicalsS11150H
Ficoll 400Sigma AldrichF9378-500G
Glass capillary, 1 X 90 mmNarshigeG-1
GlycerolFisherG33-4
HEPESFisherBP310-500
Human chorionic gonadotropinSigma AldrichCG10-10VL
Injection Syringe, 1 mLFisher8881501368
L-CysteineSigma AldrichC7352
Magnesium SulfateFisherM63-500
Needle, 26 GFisher305111
Penicillin/StreptomycinGibco15140148
Picoliter MicroinjectorWarner InstrumentsPLI-100A
Pipette PullerNarashigePC-100
Potassium ChlorideFisherP217-500
PVDF MembraneSigma AldrichIPVH00010
Sodium BicarbonateFisherS233-500
Sodium ChlorideFisherS271-10
Sodium Dodecyl SulfateFisherBP166-500
Sodium HydroxideFisherS318-500
Tricaine-SPentairTRS5
TrisFisherBP152-5

References

  1. Harrison, C. A., Al-Musawi, S. L., Walton, K. L. Prodomains regulate the synthesis, extracellular localisation and activity of TGF-beta superfamily ligands. Growth Factors. 29 (5), 174-186 (2011).
  2. Gray, A. M., Mason, A. J.

Explore More Articles

TGF betaXenopus LaevisEmbryosBlastocele FluidProteolytic CleavageAspirateMicroinjectorImmunoblotPrecursor ProteinsCleavage Products

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved